Multiple Myeloma and Exercise

Completed · Not applicable

Conditions studied: Newly Diagnosed Multiple Myeloma

In brief

This study will establich the feasibility of weight lifting exercise among patients with multiple myeloma, determine if weight lifting exercise increases lean body mass among patients with multiple myeloma and obtain further preliminary data on toxicity and pharmacokinetics of high-dose melphalan.

Key facts

Study ID: NCT01809717
Run by: Abramson Cancer Center at Penn Medicine
People needed: 10
Starts: 2013-03-01
Expected to finish: 2013-08-01
Last updated by the study team: 2020-03-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Histologically confirmed multiple myeloma
1 year since start of treatment for myeloma
Patient and treating physician in agreement to proceed with autologous transplant, with a planned time betwwen study enrollment and transplant of 10 weeks
Age 18 years.
Able to walk for 6 minutes unaided.
Body mass index 50 kg/m2
Serum creatinine 2.5 mg/dL
Ability to understand the informed consent document and willingness to consent. Written informed consent must be obtained from all patients before study entry.

You may not qualify if…

Recent (in the past 6 months) participation in progressive weight lifting exercises or who already exercise regulary (3 times a week of moderate intensity aerobic exercise).
Plan to move out of the area during the study intervention.
A psychological, social, or logistical barrier that the principal investigators feel would preclude completion of the study protocol.
Plan for use of any anti-myeloma treatment other than melphalan (the use of total body irradiation will NOT

Where it is running

Abramson Cancer Center of the Unviersity of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.